{"podcast":{"title":"Let's Combinate - Drugs + Devices","slug":"let-s-combinate-drugs-devices-4474248","podcast_index_feed_id":4474248,"rss_url":"https://anchor.fm/s/6770b9a0/podcast/rss","website_url":"https://letscombinate.com","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/17254408/17254408-1735275370987-64c671ec88d89.jpg","author":"Subhi Saadeh","episode_count":261,"summary":"Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to listen and together we can simplify by Combinating!","last_synced_at":"2026-09-07T22:17:41.545168+00:00","page_url":"https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248"},"episode":{"title":"239 - ICH Q12: What’s Binding? Established Conditions and Post-Approval Changes","slug":"239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes","published_at":"2026-05-27T12:24:18+00:00","page_url":"https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes","show_page_url":"https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248","url":"https://podcasters.spotify.com/pod/show/letscombinate/episodes/239---ICH-Q12-Whats-Binding--Established-Conditions-and-Post-Approval-Changes-e3jt5h6","audio_url":"https://anchor.fm/s/6770b9a0/podcast/play/120542182/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-26%2F424889402-44100-2-7cb3c15a0de17.mp3","summary":"In this episode, Subhi breaks down ICH Q12, the guideline focused on post-approval change management and pharmaceutical product lifecycle management. The core question behind ICH Q12 is simple: once a product is approved, what is actually binding, what is supporting information, and how should future changes be managed? This episode covers the major Q12 concepts, including reporting categories, Established Conditions, supporting information, Post-Approval Change Management Protocols, the Product Lifecycle Management document, and the role of the Pharmaceutical Quality System. Subhi also discusses why Q12 matters for drug-device combination products, where lifecycle changes may involve CMC information, device constituent parts, functional performance characteristics, and the broader control strategy. Key topics covered: Why post-approval change can become difficult after approval How ICH Q12 supports more predictable lifecycle management Reporting categories for post-approval CMC changes Established Conditions versus supporting information Examples of EC candidates, including CQAs, CPPs, material attributes, methods, sites, and process information Why overcommitting or undercommitting ECs creates lifecycle risk How PACMPs help companies plan future changes What belongs in the PLCM document How ICH Q12 applies to drug-device combination products Why a strong PQS is essential for making Q12 work Timestamps: 00:00 Introduction to ICH Q12 00:46 Why post-approval change gets difficult 02:45 Reporting categories 03:14 Established Conditions vs supporting information 04:10 EC examples: CQAs, CPPs, methods, sites, and process information 05:32 Post-Approval Change Management Protocols 06:38 PLCM document 08:08 Drug-device combination product callout 10:11 PQS and change managem…","meta_description":"In this episode, Subhi breaks down ICH Q12, the guideline focused on post-approval change management and pharmaceutical product lifecycle management. The…","key_points":[],"chapters":[],"topics":[],"duration_seconds":645,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}